Fig. 5
From: Pembrolizumab microgravity crystallization experimentation
Competitive binding assay of flight and ground dissolved crystals and complimentary mother liquors. Dissolved crystals contain binding activity >94% relative to reference pembrolizumab (N = 3, 95% CI).
